Search Results

The potential use of type-5 phosphodiesterase inhibitors in coronary artery bypass graft surgery.

• Authors : Fung E; Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.; Fiscus RR

Subjects: Coronary Artery Bypass*; 3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/*metabolism ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*therapeutic use

• Source: Chest [Chest] 2005 Oct; Vol. 128 (4), pp. 3065-73.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Retraction Notice to: "Efficacy of the Phosphodiesterase Inhibitor Enoximone in Complicated Cardiac Surgery" [Chest. 1990;98(1):53-58].

Subjects: *PHOSPHODIESTERASE inhibitors; *CARDIAC surgery

• Source: CHEST. Apr2023, Vol. 163 Issue 4, p997-998. 2p.

Record details

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

• Authors : Rennard SI; University of Nebraska Medical Center, 985885 Nebraska Medical Center, Omaha, NE 68198-5885, USA. ; Schachter N

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Nitriles/Nitriles/Nitriles/*therapeutic use ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*therapeutic use

• Source: Chest [Chest] 2006 Jan; Vol. 129 (1), pp. 56-66.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Phosphodiesterase 4 inhibitors for the treatment of COPD.

• Authors : Sturton G; Bayer plc, Pharma Research, Stoke Court, Stoke Poges, Slough SL2 4LY, Berkshire, UK. ; Fitzgerald M

Subjects: Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*therapeutic use ; Pulmonary Disease, Chronic Obstructive/Pulmonary Disease, Chronic Obstructive/Pulmonary Disease, Chronic Obstructive/*drug therapy; Aminopyridines/Aminopyridines/Aminopyridines/chemistry

• Source: Chest [Chest] 2002 May; Vol. 121 (5 Suppl), pp. 192S-196S.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry.

• Authors : Tello, Khodr^1,2 (AUTHOR); Yogeswaran, Athiththan^1,2 (AUTHOR); Majeed, Raphael W.^1,3 (AUTHOR)

Subjects: *PHOSPHODIESTERASE inhibitors; *PROPORTIONAL hazards models; *PULMONARY hypertension

• Source: CHEST. Jan2025, Vol. 167 Issue 1, p224-240. 17p.

Record details

Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.

• Authors : Prielipp RC; Department of Anesthesia, Bowman Gray School of Medicine Wake Forest University, Winston-Salem NC, USA 27157-1009.; MacGregor DA

Subjects: Critical Illness/Critical Illness/Critical Illness/*therapy ; Oxygen/Oxygen/Oxygen/*blood ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*pharmacokinetics

• Source: Chest [Chest] 1996 May; Vol. 109 (5), pp. 1291-301.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Pentoxifylline does not alter the response to inhaled grain dust.

• Authors : Jagielo PJ; Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242-1081, USA.; Watt JL

Subjects: Edible Grain* ; Zea mays*; Airway Obstruction/Airway Obstruction/Airway Obstruction/*prevention & control

• Source: Chest [Chest] 1997 May; Vol. 111 (5), pp. 1429-35.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.

• Authors : Gilbert EM; University of Utah Heart Failure Treatment Program, Salt Lake City, USA.; Hershberger RE

Subjects: Adrenergic beta-Agonists/Adrenergic beta-Agonists/Adrenergic beta-Agonists/*administration & dosage ; Cardiac Output, Low/Cardiac Output, Low/Cardiac Output, Low/*physiopathology ; Dobutamine/Dobutamine/Dobutamine/*administration & dosage

• Source: Chest [Chest] 1995 Dec; Vol. 108 (6), pp. 1524-32.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

Roflumilast in COPD.

• Authors : Worndl E; Department of Respiratory Medicine, Cork University Hospital, Cork, Ireland.; Hunt EB

Subjects: Phosphodiesterase 4 Inhibitors*; Albuterol/Albuterol/Albuterol/*analogs & derivatives ; Aminopyridines/Aminopyridines/Aminopyridines/*administration & dosage

• Source: Chest [Chest] 2015 Jul; Vol. 148 (1), pp. e31.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543

Record details

Response.

• Authors : Rho J; Division of Pulmonology and Critical Care, Department of Medicine, University of Texas Southwestern, Bethesda, MD.; Ho N

Subjects: Phosphodiesterase 4 Inhibitors*; Albuterol/Albuterol/Albuterol/*analogs & derivatives ; Aminopyridines/Aminopyridines/Aminopyridines/*administration & dosage

• Source: Chest [Chest] 2015 Jul; Vol. 148 (1), pp. e31-e32.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543

Record details